Can imaging miss brushite kidney stones?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Imaging Miss Brushite Kidney Stones?

Yes, imaging can miss brushite kidney stones, particularly when they are small (<2 mm), though noncontrast CT remains highly sensitive for detecting most clinically significant brushite stones.

Key Imaging Performance for Brushite Stones

While the guidelines do not specifically address brushite stone detection separately from other stone types, the evidence reveals important limitations:

CT Imaging Sensitivity

Noncontrast CT is the reference standard for kidney stone detection with 97% sensitivity overall 1, but this performance varies significantly by stone size and specific conditions:

  • Stones >2 mm: Detection rates of 84.7% under optimal conditions 2
  • Stones <2 mm: Detection rates drop dramatically to only 12.7% 2
  • Endoscopy comparison: CT detected an average of 5.9 stones per kidney versus 9.2 stones found at endoscopy, demonstrating that CT consistently underreports the actual number of renal calculi 3

Brushite-Specific Detection Challenges

Research using dual-energy CT protocols specifically tested brushite stones and found:

  • Optimal detection occurs at lower tube voltages (70 kV/150 kV or 80 kV/150 kV) with contrast attenuation ≤600 HU, achieving sensitivity of 96-99.6% for stones >2 mm 2
  • Higher contrast attenuation (>600 HU) significantly decreases detection rates from 91.8% to 70.7%, meaning brushite stones can be masked by surrounding contrast 2
  • Respiratory motion significantly affects dual-energy CT's ability to characterize brushite stones, as motion-induced attenuation values differ from static measurements 4

Brushite Stone Characteristics on Imaging

Brushite stones have distinct CT attenuation values (415 ± 30 Hounsfield units) that differ from other stone types 4, making them theoretically identifiable. However, brushite stones are radiopaque on plain radiography (KUB), unlike uric acid stones 5.

Clinical Implications

Common Pitfalls to Avoid

  1. Don't rely on contrast-enhanced CT alone: Contrast attenuation >600 HU can mask ureteral and small renal stones 2
  2. Small stone burden underestimation: Be aware that CT systematically underreports the total number of stones, particularly those <2 mm 3
  3. Mixed stone composition: 61.5% of brushite stones are mixed with calcium oxalate and/or carbonate apatite 6, which may affect imaging characteristics

Alternative Imaging Modalities

  • Ultrasound: Only 45% sensitive for ureteral stones and 88% specific for renal stones 5, making it inadequate as a standalone modality for brushite stone detection
  • KUB radiography: 44-77% sensitivity 5, useful for follow-up of known radiopaque stones but insufficient for initial diagnosis
  • Low-dose CT: Maintains 97% sensitivity and 95% specificity 1, though sensitivity decreases further with smaller stones and increased dose reduction 1

Recommended Imaging Approach

For suspected brushite stones, use noncontrast CT as first-line imaging 5, 1. If contrast-enhanced CT has already been performed, stones ≥6 mm have 98% detectability 1, but smaller stones may be missed.

For known brushite stone formers requiring surveillance: Consider that even optimal CT will miss small stones <2 mm, and the actual stone burden is likely higher than reported. This is particularly relevant given that brushite stone formers have high recurrence rates and often harbor multiple small stones 7, 6.

The clinical significance is that treatment planning based on CT findings may underestimate total stone burden, especially in recurrent brushite stone formers who warrant more aggressive metabolic evaluation and dietary intervention 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.